Search Results - "Klafki, H.‐W."

Refine Results
  1. 1
  2. 2
  3. 3

    The Carboxyl Termini of β-Amyloid Peptides 1-40 and 1-42 Are Generated by Distinct γ-Secretase Activities by Klafki, H.-W., Abramowski, D., Swoboda, R., Paganetti, P.A., Staufenbiel, M.

    Published in The Journal of biological chemistry (08-11-1996)
    “…We have studied the effects of peptide aldehyde protease inhibitors on the secretion of β-amyloid peptide 1-40 (Aβ(1-40)) and Aβ(1-42) by HEK 293 and COS-1…”
    Get full text
    Journal Article
  4. 4

    Immune complexes of auto-antibodies against Aβ1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients by HENKEL, A. W, DITTRICH, P. S, WILTFANG, J, GROEMER, T. W, LEMKE, E. A, KLINGAUF, J, KLAFKI, H. W, LEWCZUK, P, ESSELMANN, H, SCHWILLE, P, KORNHUBER, J

    Published in Molecular psychiatry (01-06-2007)
    “…The diagnostic potential of large Aβ-peptide binding particles (LAPs) in the cerebrospinal fluid (CSF) of Alzheimer's dementia (AD) patients and non-AD…”
    Get full text
    Journal Article
  5. 5

    Therapeutic approaches to Alzheimer's disease by Klafki, Hans-Wolfgang, Staufenbiel, Matthias, Kornhuber, Johannes, Wiltfang, Jens

    Published in Brain (London, England : 1878) (01-11-2006)
    “…Alzheimer's disease is an age-related progressive neurodegenerative disorder with an enormous unmet medical need. It is the most common form of dementia…”
    Get full text
    Journal Article
  6. 6

    N‐terminal heterogeneity of parenchymal and vascular amyloid‐β deposits in Alzheimer’s disease by Zampar, S., Klafki, H. W., Sritharen, K., Bayer, T. A., Wiltfang, J., Rostagno, A., Ghiso, J., Miles, L. A., Wirths, O.

    Published in Neuropathology and applied neurobiology (01-12-2020)
    “…Aims The deposition of amyloid‐β (Aβ) peptides in the form of extracellular plaques in the brain represents one of the classical hallmarks of Alzheimer’s…”
    Get full text
    Journal Article
  7. 7

    Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model by Hüttenrauch, M, Brauß, A, Kurdakova, A, Borgers, H, Klinker, F, Liebetanz, D, Salinas-Riester, G, Wiltfang, J, Klafki, H W, Wirths, O

    Published in Translational psychiatry (03-05-2016)
    “…The evidence for a protective role of physical activity on the risk and progression of Alzheimer’s disease (AD) has been growing in the last years. Here we…”
    Get full text
    Journal Article
  8. 8

    Calpain inhibitor I decreases βA4 secretion from human embryonal kidney cells expressing β-amyloid precursor protein carrying the APP670/671 double mutation by Klafki, Hans-W., Paganetti, Paolo A., Sommer, Bernd, Staufenbiel, Matthias

    Published in Neuroscience letters (01-12-1995)
    “…We have investigated the effects of the cell-penetrating cysteine protease inhibitors calpain inhibitor I ( N-acetyl-Leu-Leu-norleucinal) and calpain inhibitor…”
    Get full text
    Journal Article
  9. 9

    Synthesis and release of the beta-amyloid precursor protein by bovine chromaffin cells by Bieger, S, Klafki, H W, Unsicker, K

    Published in Neuroscience letters (12-11-1993)
    “…Production of the beta-amyloid precursor protein (beta APP) by bovine adrenal chromaffin cells was investigated by polymerase chain reaction (PCR) and by…”
    Get more information
    Journal Article
  10. 10

    Amyloid precursor protein truncated at any of the γ-secretase sites is not cleaved to β-amyloid by Paganetti, Paolo A., Lis, Maddalena, Klafki, Hans-Werner, Staufenbiel, Matthias

    Published in Journal of neuroscience research (01-11-1996)
    “…βA4 secretion occurs upon processing of amyloid protein precursor (APP) by β‐secretase (N‐terminus of βA4) and γ‐secretase (C‐terminus). To determine the…”
    Get full text
    Journal Article
  11. 11

    Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients by Henkel, A W, Dittrich, P S, Groemer, T W, Lemke, E A, Klingauf, J, Klafki, H W, Lewczuk, P, Esselmann, H, Schwille, P, Kornhuber, J, Wiltfang, J

    Published in Molecular psychiatry (01-06-2007)
    “…The diagnostic potential of large A beta-peptide binding particles (LAPs) in the cerebrospinal fluid (CSF) of Alzheimer's dementia (AD) patients and non-AD…”
    Get full text
    Journal Article
  12. 12

    Complete amino acid sequence determinations demonstrate identity of the urinary Bence Jones protein (BJP-DIA) and the amyloid fibril protein (AL-DIA) in a case of AL-amyloidosis by Klafki, Hans W, Kratzin, Hartmut D, Pick, Albert I, Eckart, Klaus, Karas, Michael, Hilschmann, Norbert

    Published in Biochemistry (Easton) (31-03-1992)
    “…The complete primary structures of both the main amyloid fibril protein component (AL-DIA) and the soluble Bence Jones protein (BJP-DIA) obtained from the same…”
    Get full text
    Journal Article
  13. 13

    Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43 by Wiltfang, J, Smirnov, A, Schnierstein, B, Kelemen, G, Matthies, U, Klafki, H W, Staufenbiel, M, Hüther, G, Rüther, E, Kornhuber, J

    Published in Electrophoresis (1997)
    “…Beta-amyloid peptides (A beta peptides) form the main protein component of the amyloid deposits found in the brains of Alzheimer's disease (AD) patients…”
    Get more information
    Journal Article
  14. 14
  15. 15

    Reduction of disulfide bonds in an amyloidogenic Bence Jones protein leads to formation of "amyloid-like" fibrils in vitro by Klafki, H W, Pick, A I, Pardowitz, I, Cole, T, Awni, L A, Barnikol, H U, Mayer, F, Kratzin, H D, Hilschmann, N

    Published in Biological chemistry Hoppe-Seyler (1993)
    “…Motivated by the finding that the amino acid sequence of the Bence Jones protein BJP-DIA was identical to that of the main protein component of the amyloid…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Inhibition of PHF-like tau hyperphosphorylation in SH-SY5Y cells and rat brain slices by K252a by Hübinger, Gabriele, Geis, Silvia, LeCorre, Sylvie, Mühlbacher, Susanne, Gordon, Sandra, Fracasso, R Paul, Hoffman, Fred, Ferrand, Sandrine, Klafki, Hans W, Roder, Hanno M

    Published in Journal of Alzheimer's disease (01-04-2008)
    “…Abnormal hyperphosphorylation of tau is believed to constitute a critical biochemical event in the process of neurofibrillary degeneration of Alzheimer's…”
    Get more information
    Journal Article
  18. 18

    Immune complexes of auto-antibodies against A 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients by Henkel, A W, Dittrich, P S, Groemer, T W, Lemke, E A, Klingauf, J, Klafki, H W, Lewczuk, P, Esselmann, H, Schwille, P, Kornhuber, J, Wiltfang, J

    Published in Molecular psychiatry (01-06-2007)
    “…The diagnostic potential of large A beta-peptide binding particles (LAPs) in the cerebrospinal fluid (CSF) of Alzheimer's dementia (AD) patients and non-AD…”
    Get full text
    Journal Article
  19. 19

    Distinct fractional Aβ release patterns in human mononuclear phagocytes by Maler, Juan Manuel, Spitzer, Philipp, Klafki, Hans-Wolfgang, Esselmann, Hermann, Lewczuk, Piotr, Kornhuber, Johannes, Herrmann, Martin, Wiltfang, Jens

    Published in Journal of neuroimmunology (03-01-2009)
    “…Abstract The presence of cells of the mononuclear phagocyte lineage surrounding neuritic and vascular β-amyloid (Aβ) plaques is a hallmark of Alzheimer's…”
    Get full text
    Journal Article
  20. 20

    CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction by Bibl, Mirko, Lewczuk, Piotr, Esselmann, Hermann, Mollenhauer, Brit, Klafki, Hans-Wolfgang, Welge, Volker, Wolf, Stefanie, Trenkwalder, Claudia, Otto, Markus, Kornhuber, Johannes, Wiltfang, Jens

    Published in Proteomics. Clinical applications (01-10-2008)
    “…Cerebrospinal fluid (CSF) Aβ1‐38, Aβ1‐40, and Aβ1‐42 were comparatively analyzed by amyloid‐beta SDS‐PAGE with Western immunoblot (Aβ‐SDS‐PAGE/immunoblot),…”
    Get full text
    Journal Article